Centene (CNC) Competitors $37.81 -0.64 (-1.66%) Closing price 10/9/2025 03:59 PM EasternExtended Trading$37.90 +0.09 (+0.24%) As of 08:46 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNC vs. ELV, MOH, SEM, HUM, UNH, CI, JYNT, AEMD, ZTS, and REGNShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Humana (HUM), UnitedHealth Group (UNH), Cigna Group (CI), Joint (JYNT), Aethlon Medical (AEMD), Zoetis (ZTS), and Regeneron Pharmaceuticals (REGN). These companies are all part of the "medical" sector. Centene vs. Its Competitors Elevance Health Molina Healthcare Select Medical Humana UnitedHealth Group Cigna Group Joint Aethlon Medical Zoetis Regeneron Pharmaceuticals Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, institutional ownership, dividends, profitability and earnings. Which has preferable earnings and valuation, CNC or ELV? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentene$163.07B0.11$3.31B$4.049.36Elevance Health$189.25B0.43$5.98B$23.5015.24 Do analysts prefer CNC or ELV? Centene presently has a consensus price target of $39.07, suggesting a potential upside of 3.32%. Elevance Health has a consensus price target of $414.63, suggesting a potential upside of 15.74%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts clearly believe Elevance Health is more favorable than Centene.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centene 2 Sell rating(s) 13 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.06Elevance Health 0 Sell rating(s) 7 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.63 Which has more volatility & risk, CNC or ELV? Centene has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.59, suggesting that its stock price is 41% less volatile than the S&P 500. Do insiders and institutionals have more ownership in CNC or ELV? 93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.4% of Centene shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor CNC or ELV? In the previous week, Elevance Health had 25 more articles in the media than Centene. MarketBeat recorded 46 mentions for Elevance Health and 21 mentions for Centene. Centene's average media sentiment score of 1.00 beat Elevance Health's score of 0.73 indicating that Centene is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 9 Very Positive mention(s) 5 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elevance Health 22 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Is CNC or ELV more profitable? Elevance Health has a net margin of 2.83% compared to Centene's net margin of 1.15%. Elevance Health's return on equity of 17.59% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Centene1.15% 9.57% 3.10% Elevance Health 2.83%17.59%6.36% SummaryElevance Health beats Centene on 13 of the 16 factors compared between the two stocks. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneMED IndustryMedical SectorNYSE ExchangeMarket Cap$18.88B$53.84B$6.15B$22.07BDividend YieldN/A1.83%5.66%3.58%P/E Ratio9.3610.8785.9429.59Price / Sales0.110.99629.16102.87Price / Cash3.898.9738.3224.53Price / Book0.722.2812.824.61Net Income$3.31B$2.64B$3.30B$1.01B7 Day Performance-2.34%-1.05%3.71%-0.98%1 Month Performance20.86%5.72%10.68%2.51%1 Year Performance-47.21%-30.77%81.52%14.61% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.3976 of 5 stars$37.81-1.7%$39.07+3.3%-47.7%$18.88B$163.07B9.3660,500Analyst ForecastELVElevance Health4.5808 of 5 stars$350.08-0.1%$411.06+17.4%-27.4%$78.83B$177.01B14.90104,200Trending NewsAnalyst ForecastAnalyst RevisionMOHMolina Healthcare4.5794 of 5 stars$200.77-0.6%$225.18+12.2%-39.3%$10.88B$43.41B9.9018,000Analyst ForecastSEMSelect Medical5 of 5 stars$13.03+0.8%$19.20+47.4%-59.6%$1.62B$5.28B12.2944,100News CoverageAnalyst ForecastHUMHumana4.3834 of 5 stars$295.96+4.3%$291.21-1.6%+18.2%$35.60B$117.76B22.7165,680Analyst ForecastUNHUnitedHealth Group4.7954 of 5 stars$358.95-0.3%$358.95+0.0%-37.8%$325.09B$422.82B15.55400,000Trending NewsAnalyst ForecastAnalyst RevisionCICigna Group4.9993 of 5 stars$303.30-2.5%$371.81+22.6%-11.6%$80.96B$247.12B16.5673,500Positive NewsAnalyst ForecastInsider TradeJYNTJoint3.8807 of 5 stars$8.83-2.8%$16.33+85.0%-19.7%$135.45M$51.90M-26.76320Analyst ForecastAEMDAethlon Medical2.6162 of 5 stars$0.77-2.7%$56.00+7,140.8%-76.6%$2.01MN/A-0.0610Analyst ForecastZTSZoetis4.8566 of 5 stars$145.39-0.7%$200.88+38.2%-24.6%$64.43B$9.26B25.0213,800Positive NewsDividend AnnouncementAnalyst ForecastREGNRegeneron Pharmaceuticals4.7364 of 5 stars$585.48-2.4%$817.67+39.7%-43.7%$62.05B$14.21B14.7615,106Positive NewsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies ELV Alternatives MOH Alternatives SEM Alternatives HUM Alternatives UNH Alternatives CI Alternatives JYNT Alternatives AEMD Alternatives ZTS Alternatives REGN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNC) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
